Kazia Therapeutics Limited. Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019
Kazia Therapeutics Limited. (KZIA) reported Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 of 0 AUD/shares for the 12-month period ending 2025-06-30, per its 20-F filed 2025-11-07.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 · last filed 2025-11-07
| Period end | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 12 month | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 12 month as first filed |
|---|---|---|
| 2025-06-30 | 0.00 AUD/shares 20-F · filed 2025-11-07 | |
| 2024-06-30 | 0.00 AUD/shares 20-F · filed 2025-11-07 | |
| 2023-06-30 | 0.18 AUD/shares 20-F · filed 2024-11-15 | |
| 2022-06-30 | 1.61 AUD/shares 20-F · filed 2023-10-26 | |
| 2021-06-30 | 1.09 AUD/shares 20-F · filed 2022-10-17 | 1.09 AUD/shares 20-F · filed 2021-10-07 |
| 2020-06-30 | 0.88 AUD/shares 20-F · filed 2021-10-07 | |
| 2019-06-30 | 0.49 AUD/shares 20-F · filed 2020-10-22 |